Posted by Michael Wonder on 05 Dec 2019
The Health 202: the most viable drug pricing bill in Congress is getting a makeover
5 December 2019 - The drug pricing bill with the best chances of passing Congress is getting a makeover, as its authors and the White House try to make it more attractive in a last-ditch effort to notch a win on lowering drug costs before the 2020 election season.
Sens. Chuck Grassley and Ron Wyden are poised to unveil a 2.0 version of their Prescription Drug Pricing Reduction Act of 2019, which caps out-of-pocket costs for Medicare enrollees and requires drugmakers to pay rebates if they hike prices faster than inflation.
The revisions, which the White House says it supports, are expected to bring further cost relief to seniors, and aides predict the bill could win much-needed support from more GOP law makers.
